# Opus Genetics (IRD) — News

IRD · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ird/news

## Recent headlines

- [Opus Genetics' OPGX-LCA5 shows gains through 24 months](https://www.ainvest.com/news/opus-genetics-opgx-lca5-shows-gains-24-months-2610) — AInvest Wire, Oct 15, 2026
- [Opus Genetics Inc: Jonestrading raises target price to $17 from $10](https://www.ainvest.com/news/opus-genetics-jonestrading-raises-target-price-17-10-2610) — AInvest Wire, Oct 6, 2026
  Jonestrading has revised its target price for Opus Genetics Inc (IRD) to $17 from $10, reflecting a 70% increase in its valuation forecast. The adjustment follows a reassessment of the company’s operational performance and market positioning. While the firm’s operations have been described as "too…
- [Opus Genetics - OPGX-Best1 demonstrates favorable safety with no serious adverse events or dose-limiting toxicities](https://www.ainvest.com/news/opus-genetics-opgx-best1-demonstrates-favorable-safety-adverse-events-dose-limiting-toxicities-2609) — AInvest Wire, Sep 9, 2026
- [Opus Genetics - Cohort 2 dosing to complete in Q4 2026, topline data expected Q2 2027](https://www.ainvest.com/news/opus-genetics-cohort-2-dosing-complete-q4-2026-topline-data-expected-q2-2027-2609) — AInvest Wire, Sep 9, 2026
- [Opus Genetics - FDA aligns on ≥3 decibels microperimetry improvement as potential pivotal endpoint](https://www.ainvest.com/news/opus-genetics-fda-aligns-3-decibels-microperimetry-improvement-potential-pivotal-endpoint-2609) — AInvest Wire, Sep 9, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).